Skip to main content
. 2022 Sep 15;112(5):571–584. doi: 10.1007/s00392-022-02095-y

Fig. 1.

Fig. 1

Mitral regurgitation (MR) severity was assessed at baseline (A) and paravalvular regurgitation (PVL) at discharge (B). At baseline, 55.0% of patients had MR moderate or severe in the group treated with a balloon-expandable valve. At discharge one patient of the fifteen (7.7%) treated patients with a self-expanding valve had severe PVL. MR mitral regurgitation, BAV balloon-expandable valve, PVL paravalvular regurgitation, SAV self-expanding valve